
A breakthrough in the treatment of Parkinson's disease (PD) has emerged from Delhi University, offering hope to over 10 million affected individuals worldwide. PD, a neuro-degenerative disorder causing tremors, stiffness, and mobility issues, currently lacks a cure. Delhi University Professor Diwan S. Rawat, in collaboration with Professor Kim at McLean Hospital, US, has developed a promising molecule, ATM 399A. Clinical trials, supported by the Michael J. Fox Foundation, are underway in the US. Rawat emphasized the challenges faced in the research journey, highlighting the potential benefits for humanity. Phase 1 results are anticipated by the second half of 2024.
Like
Save
Share